Clinical Trial Update: Melflufen for Elderly Patients With Relapsed Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial of Melflufen in elderly patients with relapsed multiple myeloma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melflufen (melphalan flufenamide)

Snippet

Sponsor: Fondazione EMN Italy Onlus | Conditions: Relapse Multiple Myeloma | Phase 2 | Status: WITHDRAWN